100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
NR 325 - FINAL EXAM STUDY GUIDE, (Answered) Complete Verified Solution, Over 280 Questions Ans Correct Answers $12.49   Add to cart

Exam (elaborations)

NR 325 - FINAL EXAM STUDY GUIDE, (Answered) Complete Verified Solution, Over 280 Questions Ans Correct Answers

 0 view  0 purchase
  • Course
  • Institution

NR 325 - FINAL EXAM STUDY GUIDE, (Answered) Complete Verified Solution, Over 280 Questions Ans Correct Answers BREAST CANCER SCREENING GUIDELINES regular screening mammography starting at age 45 years. Women aged 45 to 54 years should be screened annually. Women 55 years and older should ...

[Show more]

Preview 4 out of 37  pages

  • June 30, 2023
  • 37
  • 2022/2023
  • Exam (elaborations)
  • Questions & answers
avatar-seller
NR 325 - FINAL EXAM STUDY GUIDE, (Answered)
Complete Verified Solution, Over 280 Questions Ans
Correct Answers
BREAST CANCER SCREENING GUIDELINES
regular screening mammography starting at age 45 years.

Women aged 45 to 54 years should be screened annually.

Women 55 years and older should transition to biennial screening or have the
opportunity to continue screening annually.

continue screening mammography as long as overall health is good and life expectancy
is 10 years or longer
THE BREAST SELF-EXAMINATION
lie down and place one arm behind the head

use finger pads of three middle fingers of the other hand to feel for lumps

use overlapping dime-sized circular motions to feel the breast tissue

use three different levels of pressure

up-and-down vertical pattern is recommended

stand in a front a mirror; examine breasts for:
- shape
- size
- redness/scaliness
- dimpling (skin/nipple)
MASTITIS
inflammation of the breast

occurs in up to 10% of postpartum lactating mothers 2-4 weeks after birth
MASTITIS - CLINICAL MANIFESTATIONS
warm to touch

indurated/painful

often unilateral

most commonly caused by staphylococcus aureus
BEST TIME TO PERFORM SELF BREAST EXAM (BSE)

,Perform BSE at the end of the menstrual period

breast tenderness is less likely to occur
RISK FACTORS FOR BREAST CANCER
early menarche

late menopause

Age - at or older than 50 yrs

hormone use

Family history/Genetics

History of cancer (breast, colon, endometrial, ovarian)

First full term pregnancy after age 30

nulliparity (never given birth)

benign breast disease (atypical epithelial hyperplasia)

weight gain/obesity after menopause

exposure to ionizing radiation

alcohol consumption
ADVANTAGE OF FINE-NEEDLE ASPIRATION (FNA) BIOPSY
FNA is performed in outpatient settings

results are available within 24-48 hours

no incision required
BREAST LUMPS - ASSESSMENT
painless and fixed lumps suggest breast cancer/malignancy
HORMONE THERAPY (HT)
HT has been linked to increased risk for breast cancer; patient and HCP must
determine whether or not HT therapy is appropriate

Breast cancer incidence is increased in women using HT, independent of other risk
factors

HT increases the risk for both non-BRCA-associated cancer and BRCA-related cancers
CLASSIFICATION OF BREAST CANCER
based on tissue type

,based on invasiveness

based on hormone receptor and genetic status
CLASSIFICATION OF BREAST CANCER - BASED ON ON TISSUE TYPE
Ductal carcinoma (milk ducts)
- Medullary
- Tubular
- Colloid (mucinous)

Lobular carcinoma (milk-producing glands)

Other
- Inflammatory
- Paget's disease
- Phyllodes tumor
CLASSIFICATION OF BREAST CANCER - BASED ON INVASIVENESS
Noninvasive (In situ)
- ductal carcinoma in situ (DCIS)
- lobular carcinoma in situ (LCIS)

Invasive (spreads)
- invasive ductal carcinoma
- invasive lobular carinoma
CLASSIFICATION OF BREAST CANCER - BASEDON HORMONE RECEPTOR
STATUS/GENETIC STATUS
Estrogen and Progesterone Receptor Status
- Estrogen receptor positive
- Estrogen receptor negative
- Progesterone receptor positive
- Progesterone receptor negative

HER-2 Genetic Status
- HER-2 positive
- HER-2 negative
TRASTUZUMAB (HERCEPTIN) - THERAPEUTIC USE
this Rx is for the treatment of of tumors that have the HER-2 receptor
TRASTUZUMAB (HERCEPTIN) - ADVERSE EFFECT
this Rx can lead to ventricular dysfunction

patient is taught to self-monitor for symptoms of heart failure
TAMOXIFEN (NOLVADEX - THERAPEUTIC USE
this Rx is for the treatment of estogen-dependent breast tumors in premenopausal
women
ESTRADIOL - CAUTION
this Rx will increase the growth of estrogen-dependent tumors
RALOXIFENE - THERAPEUTIC USE

, this Rx is used to prevent breast cancer

this Rx IS NOT USED postmastectomy
RADICAL MASTECTOMY - POST OP NURSING CARE
patients are at increased risk for lymphedema and infection

therefore, NO BLOOD PRESSURES OR VENIPUNCTURES in the affected arm

signage should be posted at the bedside to help remind staff
RADICAL MASTECTOMY - PATIENT TEACHING
patients should avoid any activity that might injure the affected arm

analgesics can be used

exercises should be continued in order restore strength/ROM

affected arm should be elevate at or above the heart to improve ROM/function
SITES OF BREAST CANCER RECURRENCE/METASTASIS
LOCAL RECURRENCE
skin
chest wall

REGIONAL RECURRENCE
lymph nodes

DISTAL METASTASIS
skeletal
spinal cord
brain
pulmonary
liver
bone marrow
TNM SYSTEM OF STAGING & PROGNOSIS
T = tumor size

N = nodal involvement

M = metastasis
TUMOR SIZE AS PROGNOSTIC INDICATOR
the larger the tumor, the poorer the prognosis

well differentiated the tumors = less aggressive

poorly differentiated tumors = more aggressive
RECEPTOR-POSITIVE TUMORS

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller ACADEMICAIDSTORE. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $12.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75759 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$12.49
  • (0)
  Add to cart